Loading...
  • oral cavity
  • O papel da concentra o salivar e s rica da prote na SLPI (inibidor de protease secretada por leuc citos) na progress o do carcinoma epidermoide da cavidade bucal / The Role of Tumor Expression and Salivary and Serum Concentration of Protein SLPI (Protein Inhibitor Secreted by Leukocytes) in Progression of Squamous Cell Carcinoma of the Oral Cavity. (bireme.br)
  • Methodology: Serum SLPI was quantified by ELISA in patients with squamous cell carcinoma of the oral cavity treated at the Hospital Heli polis of the State Health Department of the State of S o Paulo in the period between 2011 and 2017. (bireme.br)
  • CD1a
  • Tissue biopsy of lesional cells showing the presence of CD1a and langerin (CD207) is definitive for diagnosis in the correct clinical setting. (bmj.com)
  • myeloid cells
  • Increased understanding of LCH pathogenesis will provide opportunities to optimize and personalize therapy through improved risk-stratification, targeted therapy and assessment of therapy response based on specific molecular features and origin of the pathological myeloid cells. (nih.gov)
  • lymph nodes
  • Others sample the invasion site and carry bits of information back to lymph nodes where they initiate an immune response that directs the migration of effector cells back to the invasion site. (dana-farber.org)
  • Dendritic cells display a large amount of MHC-peptide complexes at their surface and can increase the expression of costimulatory receptors and migrate to the lymph nodes, spleen, and other lymphoid tissues, where they activate specific T cells. (medscape.com)
  • Lymph node: Enlargement of the liver in 20%, spleen in 30% and lymph nodes in 50% of Histiocytosis cases. (wikipedia.org)
  • LOH can be detected in microdissected LAM cells, in angiomyolipomas and lymph nodes from women with LAM, and in circulating LAM cells (cells in blood and urine). (wikipedia.org)
  • characteristic
  • D) Regardless of cell of origin, the pathological DCs recruit 'bystander' immune cells in an inflammatory lesion characteristic of LCH. (nih.gov)
  • lymphoma
  • Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma and positive interim PET after 4 cycles of R-CHOP-14. (fecri.org.au)
  • malignant
  • New therapeutic targets have emerged from studies of the genetic profile of melanocytes and from the identification of molecular factors involved in the pathogenesis of the malignant transformation. (readbyqxmd.com)
  • tumor cells
  • Chemokines can stimulate leukocytes to engage in host antitumor activity, but some chemokines can affect tumor cells directly. (dana-farber.org)
  • Recently, we demonstrated that ambient chemokines stimulate anti-apoptotic responses in tumor cells. (dana-farber.org)
  • The defects in proto-oncogenes have been well documented and evaluated mostly in tumor cells, despite the fact that proto-oncogenes are expressed in all cells, including cells of the immune system. (readbyqxmd.com)
  • Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells. (fecri.org.au)
  • benign
  • This, together with the fact that recurrent LAM after lung transplantation carries the same TSC2 mutations as the original LAM, has led to the "benign metastasis" hypothesis that LAM cells can migrate or metastasize from one site to another. (wikipedia.org)
  • reactive
  • The pathogenesis (medical cause) is not clearly understood and an ongoing debate continues regarding its cause as a reactive immunologic or neoplastic ( cancer -like) process. (webmd.com)
  • immune responses
  • We have also discovered that MCP-1 is required for the development of type 2 T helper cell-polarized immune responses, that is, those that fight parasites and are involved in allergies. (dana-farber.org)